The Analytics Advantage in M&A Due Diligence
How data-driven approaches are transforming deal discovery and risk identification in complex transactions — and what finance leaders need to know before the next deal.
I help organizations navigate complex transactions and transform their finance functions — turning ambiguity into action through rigorous analytics and disciplined execution.
Supporting QoE and commercial due diligence for a $1B+ pharmaceutical acquisition — delivering risk-ranked analytics that accelerated executive decision-making.
Led a finance transformation that automated 78% of month-end close activities and compressed the reporting cycle from 18 days to 5.
Took a proof-of-concept analytics tool into production, reducing manual data preparation time by 90% and enabling same-day inventory decisions.
Thirteen years of turning M&A complexity into decisions organizations can act on.
I'm a Director at KPMG US, embedded in some of the most analytically demanding M&A and finance transformation engagements in the market. My work lives at the intersection of rigorous data analysis, practical automation, and strategic advisory — always with a focus on outcomes that outlast the engagement.
I've led teams across Life Sciences, TMT, Consumer & Retail, and Industrial Manufacturing — building analytics capabilities that move from ambiguity to clarity, and from proof-of-concept to production.
My Full StoryHow data-driven approaches are transforming deal discovery and risk identification in complex transactions — and what finance leaders need to know before the next deal.
The steps finance leaders can take to modernize their function without disrupting day-to-day operations — drawing on patterns from engagements across multiple sectors.
Whether you're navigating a transaction, modernizing your finance function, or building analytics capabilities — I'd like to hear about it.